Clinical Trials Directory

Trials / Completed

CompletedNCT04050384

Effect of a Vibratory Stimulus on Mitigating Nociception-specific Responses to Skin Puncture in Neonates

Effect of a Vibratory Stimulus on the Mitigation of Nociception-specific Behavioral and Electroencephalographic Responses to Skin Puncture in Neonates: a Randomized Control Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
134 (actual)
Sponsor
Lance M Relland, MD, PhD · Academic / Other
Sex
All
Age
36 Weeks – 56 Weeks
Healthy volunteers
Accepted

Summary

The assessment and treatment of pain in neonates remains a challenge. In an effort to improve the quality of care while limiting opioid-related adverse effects, this study aims to determine the efficacy of a non-pharmacological intervention on the mitigation of nociception-specific responses to a skin breaking procedure in term and preterm neonates. Such responses will be measured using behavioral measures as well as with electroencephalography-based methods.

Detailed description

Eligible neonates who are 36-56 weeks post-menstrual age and who are scheduled to undergo a clinically required heel lance will be studied after obtaining appropriate verbal and written consent from the respective parents. Subjects will be monitored during a baseline resting state, during vibratory stimuli alone, and during a heel lance that is randomized to be preceded or not preceded by the vibratory stimulus. The sessions will include time-locked video recordings and electroencephalography using a specialized net of 128 electrodes (Electrical Geodesics Inc., EGI; Eugene, OR). Behavioral and cortical responses will be then be analyzed in a blinded fashion to determine the efficacy of the vibratory intervention, as well as to validate what behavioral responses are most correlated with nociception-specific cortical activity.

Conditions

Interventions

TypeNameDescription
DEVICEBaby GentleStickThe Baby GentleStick is a handheld device that fits and provides vibration to an Owen Mumford Unistik3 Dual lancet. The gentle vibration occurs at 178 Hertz with a free-hanging 0.24 mm range of motion. The device may provide vibration alone and also allow for simultaneous vibration and deployment of the lancet.

Timeline

Start date
2018-11-13
Primary completion
2020-01-23
Completion
2020-01-23
First posted
2019-08-08
Last updated
2023-11-29
Results posted
2023-11-29

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04050384. Inclusion in this directory is not an endorsement.